Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedLocations section expanded with numerous new sites across the US, Canada, Europe, and other regions, and some sites were removed. This changes the set of enrollment locations for the study.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new publication citation by Dasgupta et al. was added to Publications. The existing online-ahead-of-print entry was removed and the revision/version updated to v3.3.2.SummaryDifference0.1%

- Check44 days agoChange DetectedPublications section now notes that PubMed-sourced items are automatically filled and may not pertain to the study. Revision tags updated to v3.3.1 in additions and v3.2.0 in deletions.SummaryDifference0.1%

- Check52 days agoChange DetectedPublication list updated with a 2025 JAMA Cardiol article on acoramidis. A government funding lapse notice has been removed.SummaryDifference0.2%

- Check66 days agoChange DetectedExternal resource links and some study documents were removed from the page; the primary study details remain unchanged.SummaryDifference0.7%

- Check73 days agoChange DetectedExternal reference links to MedlinePlus genetics, PubMed, DailyMed, and related resources have been removed from the Study Details page.SummaryDifference0.7%

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.